Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Cancer
76%
Non Small Cell Lung Cancer
68%
Chronic Obstructive Lung Disease
67%
Mouse
66%
Inflammation
64%
Cohort Study
59%
Asthma
53%
Disease
51%
Lung Adenocarcinoma
49%
Neoplasm
43%
Sleep Disordered Breathing
43%
Malignant Neoplasm
43%
Thrombin
42%
Phosphotransferase
42%
Nuclear Factor
36%
Alternative Complement Pathway C3 C5 Convertase
36%
Connective Tissue Growth Factor
35%
Mycobacterium Tuberculosis
35%
Lung Tuberculosis
34%
Polycyclic Aromatic Hydrocarbon
33%
Cyclooxygenase 2
33%
Multi-Drug-Resistant Tuberculosis
32%
Tuberculostatic Agent
32%
Tumor Necrosis Factor
30%
Interleukin 6
30%
Epidermal Growth Factor Receptor Kinase Inhibitor
26%
Mitogen Activated Protein Kinase
25%
Quinolone Derivative
25%
Tuberculosis
24%
Protein Tyrosine Kinase Inhibitor
24%
Adverse Event
24%
Cytokine
23%
Chemotherapy
23%
Protein Kinase C
23%
Biological Marker
22%
Pleura Effusion
22%
Emphysema
21%
Overall Survival
21%
Randomized Controlled Trial
20%
Cytotoxicity
20%
Infection
20%
Effusion
20%
Plasminogen Activator Inhibitor 1
20%
Diabetes Mellitus
19%
Transforming Growth Factor
19%
Long Term Exposure
19%
Zinc Oxide Nanoparticle
18%
Reactive Oxygen Metabolite
18%
Uridine Triphosphate
18%
Rifampicin
18%
Small Interfering RNA
18%
Carbon Black
17%
Interleukin 8
17%
Coronavirinae
17%
Isoniazid
16%
Fibrosis
16%
Progression Free Survival
16%
Prevalence
16%
Organic Carbon
16%
Lactate Dehydrogenase
16%
Endothelin 1
16%
Cell Viability
16%
Lipopolysaccharide
16%
Chronic Kidney Failure
15%
Ovalbumin
15%
Luciferase
15%
Drug Resistance
15%
SARS Coronavirus
15%
Immunotherapy
14%
Histone Deacetylase Inhibitor
14%
Nitric Oxide
14%
Peptidoglycan
14%
Fibrinogen
14%
Drug Resistant Tuberculosis
14%
Transcription Factor AP 1
12%
Observational Study
12%
Cigarette Smoke
12%
Recurrent Disease
11%
Adenocarcinoma
11%
Western Blot
11%
Normal Human
11%
Adenosine Triphosphate
11%
Inducible Nitric Oxide Synthase
11%
Calcium Ion
10%
Nanoparticle
10%
Lung Disease
10%
Comorbidity
10%
Uvomorulin
10%
Pneumonia
10%
Single Chain Fragment Variable Antibody
10%
Pharmacokinetics
10%
Cardiovascular Disease
10%
Metalloproteinase
10%
Caspase 3
10%
Hypoxia
10%
Sleep Disorder
10%
Gefitinib
9%
Vasculotropin
9%
Respiratory Tract Allergy
9%
Medicine and Dentistry
Lung Cancer
69%
Epidermal Growth Factor Receptor
63%
Cohort Analysis
59%
Chronic Obstructive Pulmonary Disease
59%
Multidrug Resistant Tuberculosis
57%
Lung Tuberculosis
49%
Non Small Cell Lung Cancer
42%
Meta-Analysis
42%
Particular Matter 2.5
38%
Tuberculosis Treatment
32%
Asthma
31%
Disease
31%
Lung Adenocarcinoma
30%
Hazard Ratio
29%
Obstructive Sleep Apnea
28%
Odds Ratio
27%
Infection
26%
Medicine
26%
Atmospheric Aerosol
26%
Diabetes Mellitus
25%
COVID-19
22%
Systematic Review
21%
Chronic Kidney Disease
21%
Pleura Effusion
21%
Neoplasm
21%
Mycobacterium Tuberculosis
20%
Drug Resistant Tuberculosis
20%
Plasminogen Activator Inhibitor-1
19%
Prevalence
19%
Tuberculosis
19%
Tuberculostatic Agent
18%
In Vitro
17%
Overall Survival
17%
Tyrosine-Kinase Inhibitor
16%
Effusion
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Cancer Cell
16%
Rifampicin
16%
Metastatic Carcinoma
16%
Quinolone Derivative
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Mesothelial Cell
15%
Programmed Cell Death
15%
Intensive Care Unit
15%
Phosphotransferase
15%
Patient-Data
15%
Adverse Event
15%
Observational Study
15%
Tumor Necrosis Factor
14%
Smoking
14%
Polycyclic Aromatic Hydrocarbon
14%
Systemic Lupus Erythematosus
14%
Influenza Vaccination
14%
Malignant Neoplasm
14%
Drug Sensitivity
14%
Diagnosis
13%
Retrospective Cohort Study
12%
Biological Marker
12%
Drug Resistance
12%
Emphysema
11%
4 Iodo 2,5 Dimethoxyamphetamine
11%
Fine Particulate Matter
11%
Progression Free Survival
11%
Symptom
11%
Diabetes
11%
Cytotoxicity
11%
Sepsis
10%
Rheumatoid Arthritis
10%
Non-Small Cell Lung Cancer
10%
Chest Radiograph
10%
Injury
10%
Proportional Hazards Model
10%
Drug Therapy
10%
Macrophage
10%
Extensively Drug Resistant Tuberculosis
9%
Recurrent Disease
9%
Epithelial Cell
9%
Silo-Filler's Disease
9%
Nucleic Acid Amplification
9%
Apoplexy
9%
Surgery
9%
Forced Expiratory Volume
9%
Isoniazid
9%
Malignant Pleural Effusion
9%
Tretinoin
9%
Durvalumab
9%
Pleural Fibrosis
9%
Cytokine
9%
Amino Terminal Sequence
9%
Continuous Positive Airway Pressure
9%
Cancer
9%
Histone Deacetylase Inhibitor
8%
Mitogen-Activated Protein Kinase
8%
Computer Assisted Tomography
8%
Cross Sectional Study
8%
Public Health
8%
Artificial Respiration
8%
Nephrotoxicity
8%
Fibrinogen
8%
Adenocarcinoma
8%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
48%
Kinase
39%
Phosphotransferase
38%
Fibroblast
37%
Cohort Study
35%
Connective Tissue Growth Factor
31%
Macrophage
21%
Thrombin
20%
Interleukin 8
18%
K-Complex
18%
Particulate Matter
15%
Breathing
14%
Cancer Cell
14%
Small Interfering RNA
14%
Mycobacterium Tuberculosis
13%
Prevalence
12%
Tyrosine Kinase Inhibitor
12%
Body Mass
12%
Heart Rate Variability
11%
Cyclooxygenase
11%
Promoter Region
11%
down Regulation
10%
Upregulation
10%
Hemodialysis
10%
Platelet
10%
Drug Resistance
10%
Messenger RNA
9%
Signal Transduction
9%
Tretinoin
9%
Luciferase
9%
Smoking
9%
Observational Study
9%
Protein Kinase C
9%
Autophagy
9%
Overall Survival
9%
Immune Checkpoints
9%
Extracellular Signal-Regulated Kinases
9%
N-Terminus
8%
Cell Death
8%
Lipopolysaccharide
8%
Blood Level
8%
Proteomics
8%
Lung Function
8%
AP-1 Transcription Factor
8%
Normal Human
8%
P38 Mitogen-Activated Protein Kinases
8%
Eicosanoid Receptor
8%
Mouse
7%
Oxygen Desaturation
7%
Metalloproteinase
7%
Metalloendopeptidase
7%
Systolic Blood Pressure
7%
Endothelin 1
7%
Transforming Growth Factor
7%
Ccaat-Enhancer-Binding Proteins
7%
Western Blot
7%
Genotyping
7%
Retrospective Study
7%
Blood Pressure
7%
Histone Deacetylase
7%
Disintegrin
7%
Body Water
7%
Peptidoglycan
7%
Agonist
7%
Angiogenesis
6%
Monospecific Antibody
6%
Protein Expression
6%
Gene Expression
6%
Wild Type
6%
Medline
6%
T Cell
6%
C-Reactive Protein
6%
Immunocompetent Cell
6%
Complement Factor B
6%
Leukocyte
6%
Tumor Progression
6%
Oxidative Stress
6%
Survival Rate
6%
Nitric Oxide Synthase
6%
Enzyme
6%
Interleukin-6
6%
P53
5%
Pharmacokinetics
5%
Sulfur Dioxide
5%
Whole Genome Sequencing
5%
Actin
5%
Progression Free Survival
5%
Medical Record
5%
Receptor Tyrosine Kinase Inhibitors
5%
Forced Expiratory Volume
5%
Body Composition
5%
Mitogen-Activated Protein Kinase
5%
Cell Proliferation
5%
STAT3
5%
Droplet Digital Polymerase Chain Reaction
5%
Randomized Controlled Trial
5%
Coagulation System
5%
Diastolic Blood Pressure
5%
Random Forest
5%
Comorbidity
5%